{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:17:56Z","timestamp":1787642276497,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:00:00Z","timestamp":1768694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006479","name":"Cordis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031956","name":"Shockwave Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016242","name":"Boston Scientific Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejvs.2026.01.030","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:46:27Z","timestamp":1769042787000},"page":"928-941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Editor's Choice \u2013 Dynamic Risk of Death following Application of Paclitaxel Coated Devices in the Femoropopliteal Artery: A Contemporary Meta-analysis of Randomised Controlled Trials"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6312-1836","authenticated-orcid":false,"given":"Konstantinos","family":"Katsanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1860-0568","authenticated-orcid":false,"given":"Stavros","family":"Spiliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Saratzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Teichgr\u00e4ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5023-5834","authenticated-orcid":false,"given":"Hany","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-2068","authenticated-orcid":false,"given":"Panagiotis","family":"Kitrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miltiadis","family":"Krokidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Karnabatidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2026.01.030_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2026.01.030_bib2","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices: an individual patient data meta-analysis","volume":"141","author":"Rocha-Singh","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2026.01.030_bib3","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0140-6736(23)02189-X","article-title":"Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis","volume":"402","author":"Parikh","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2026.01.030_bib4","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib5","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.jcin.2019.08.025","article-title":"Safety of paclitaxel-coated balloon angioplasty for femoropopliteal peripheral artery disease","volume":"12","author":"Ouriel","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s42155-019-0069-x","article-title":"Zilver PTX RCT mortality analysis: no difference in long-term mortality rate for Zilver PTX drug-eluting stent compared to PTA\/BMS","volume":"2","author":"Dake","year":"2019","journal-title":"CVIR Endovasc"},{"key":"10.1016\/j.ejvs.2026.01.030_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.carrev.2021.04.010","article-title":"A patient-level, pooled analysis of mortality rates with the passeo-18 lux paclitaxel drug-coated balloon in peripheral arterial disease","volume":"33","author":"Forrestal","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ejvs.2026.01.030_bib8","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jvir.2024.05.018","article-title":"Paclitaxel meta-analyses in the lower limbs: missing the trees for the forest","volume":"35","author":"Katsanos","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib9","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.ejvs.2026.01.030_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2026.01.030_bib12","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2026.01.030_bib13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2026.01.030_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jrsm.1160","article-title":"Get real in individual participant data (IPD) meta-analysis: a review of the methodology","volume":"6","author":"Debray","year":"2015","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ejvs.2026.01.030_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jrsm.1384","article-title":"Individual participant data meta-analysis of intervention studies with time-to-event outcomes: a review of the methodology and an applied example","volume":"11","author":"de Jong","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ejvs.2026.01.030_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.ejvs.2026.01.030_bib18","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/sim.6556","article-title":"Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data","volume":"34","author":"Wei","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.ejvs.2026.01.030_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.21037\/atm.2018.02.12","article-title":"Time-varying covariates and coefficients in Cox regression models","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ejvs.2026.01.030_bib20","article-title":"NICE DSU technical support document 21: flexible methods for survival analysis. Sheffield: Decision Support Unit, ScHARR","author":"Rutherford","year":"2020","journal-title":"University of Sheffield"},{"key":"10.1016\/j.ejvs.2026.01.030_bib21","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/0962280216664760","article-title":"Parametric and penalized generalized survival models","volume":"27","author":"Liu","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ejvs.2026.01.030_bib22","article-title":"Introduction to the rstpm2 package","author":"Clements","year":"2019","journal-title":"Solna: Karolinska Institutet"},{"key":"10.1016\/j.ejvs.2026.01.030_bib23","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1002\/sim.3064","article-title":"Flexible parametric models for relative survival, with application in coronary heart disease","volume":"26","author":"Nelson","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.ejvs.2026.01.030_bib24","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/sim.4274","article-title":"The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt","volume":"30","author":"Royston","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.ejvs.2026.01.030_bib25","author":"Uno"},{"key":"10.1016\/j.ejvs.2026.01.030_bib26","author":"Uno"},{"key":"10.1016\/j.ejvs.2026.01.030_bib27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12874-020-01098-5","article-title":"Dynamic RMST curves for survival analysis in clinical trials","volume":"20","author":"Liao","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jrsm.1053","article-title":"GOSH - a graphical display of study heterogeneity","volume":"3","author":"Olkin","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ejvs.2026.01.030_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2026.01.030_bib31","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jvs.2021.07.244","article-title":"Four-year patient-level pooled mortality analysis of the ILLUMENATE US Pivotal and EU randomized controlled trials","volume":"75","author":"Lyden","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2026.01.030_bib32","article-title":"Five-year independent patient-level mortality analysis of the pooled ILLUMENATE pivotal and EU randomized controlled trials","volume":"2","author":"Lyden","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib33","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2026.01.030_bib34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jcin.2018.01.276","article-title":"12-month results from the first-in-human randomized study of the ranger paclitaxel-coated balloon for femoropopliteal treatment","volume":"11","author":"Steiner","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib35","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2026.01.030_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib38","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","article-title":"Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the AcoArt I trial","volume":"9","author":"Jia","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib39","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jvs.2021.01.041","article-title":"Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial","volume":"74","author":"Xu","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2026.01.030_bib40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1358863X20988360","article-title":"Microcrystalline paclitaxel-coated balloon for revascularization of femoropopliteal artery disease: three-year outcomes of the randomized BIOPAC trial","volume":"26","author":"Nowakowski","year":"2021","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2026.01.030_bib41","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00270-019-02194-w","article-title":"Two-year mortality after angioplasty of the femoro-popliteal artery with uncoated balloons and paclitaxel-coated balloons-a pooled analysis of four randomized controlled multicenter trials","volume":"42","author":"Albrecht","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib42","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2026.01.030_bib43","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00270-017-1713-2","article-title":"Angiographic and clinical outcomes after treatment of femoro-popliteal lesions with a novel paclitaxel-matrix-coated balloon catheter","volume":"40","author":"Tepe","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib44","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00270-022-03265-1","article-title":"Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty: 5-year results of the randomized controlled EffPac trial","volume":"45","author":"Teichgr\u00e4ber","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijcard.2020.10.060","article-title":"Reewarm\u2122 PTX drug-coated balloon in the treatment of femoropopliteal artery disease: a multi-center, randomized controlled trial in China","volume":"326","author":"Ye","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib46","first-page":"679","article-title":"Drug coated balloon supported Supera stent versus Supera stent in intermediate and long-segment lesions of the superficial femoral artery: 2-year results of the RAPID Trial","volume":"60","author":"de Boer","year":"2019","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.ejvs.2026.01.030_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.ejvs.2026.01.030_bib48","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00270-019-02309-3","article-title":"The randomized freeway stent study: drug-eluting balloons outperform standard balloon angioplasty for postdilatation of nitinol stents in the SFA and PI segment","volume":"42","author":"Tacke","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00270-023-03646-0","article-title":"Long-term follow-up and mortality rate of patients of the randomized freeway stent study","volume":"47","author":"Hausegger","year":"2024","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.23736\/S0392-9590.19.04243-3","article-title":"Randomized controlled trial of orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for treatment of femoropopliteal artery in-stent restenosis","volume":"38","author":"Liao","year":"2019","journal-title":"Int Angiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib51","first-page":"1087","article-title":"Paclitaxel exposure: long-term safety and effectiveness of a drug-coated balloon for claudication in pooled randomized trials","volume":"96","author":"Schneider","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.avsg.2018.04.042","article-title":"Drug-coated versus plain balloon angioplasty in bypass vein grafts (the DRECOREST I-study)","volume":"55","author":"Bj\u00f6rkman","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2026.01.030_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.avsg.2020.08.147","article-title":"No difference in mid-term and long-term mortality after vascular paclitaxel exposure","volume":"72","author":"Bj\u00f6rkman","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2026.01.030_bib54","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/1526602820948240","article-title":"Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty","volume":"27","author":"Soga","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.ejvs.2026.01.030_bib55","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib56","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1161\/CIRCULATIONAHA.116.025329","article-title":"Randomized comparison of paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH)","volume":"135","author":"Ott","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2026.01.030_bib57","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006321","article-title":"ISAR-PEBIS (paclitaxel-eluting balloon versus conventional balloon angioplasty for in-stent restenosis of superficial femoral artery): a randomized trial","volume":"6","author":"Ott","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2026.01.030_bib58","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jcin.2013.07.010","article-title":"Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery)","volume":"6","author":"Liistro","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib59","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/CIRCULATIONAHA.115.017364","article-title":"Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized femoral artery in-stent restenosis (FAIR) trial","volume":"132","author":"Krankenberg","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2026.01.030_bib60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00270-019-02324-4","article-title":"Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices","volume":"43","author":"Dake","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib61","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2026.01.030_bib62","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s00270-023-03549-0","article-title":"ZILVERPASS study: ZILVER PTX stent versus prosthetic above-the-knee bypass surgery in femoropopliteal lesions, 5-year results","volume":"46","author":"Bosiers","year":"2023","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib63","first-page":"413","article-title":"ZILVERPASS study: ZILVER PTX stent vs. bypass surgery in femoropopliteal lesions, 3 year results and economic analysis","volume":"64","author":"Bosiers","year":"2023","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.ejvs.2026.01.030_bib64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.avsg.2018.04.014","article-title":"Drug-eluting stent shows similar patency results as prosthetic bypass in patients with femoropopliteal occlusion in a randomized trial","volume":"53","author":"Bj\u00f6rkman","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2026.01.030_bib65","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcin.2019.12.028","article-title":"A polymer-free paclitaxel-eluting stent versus a bare-metal stent for de novo femoropopliteal lesions: the BATTLE trial","volume":"13","author":"Gou\u00ebffic","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib66","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006564","article-title":"Drug-eluting versus bare-metal stent implantation with or without cilostazol in the treatment of the superficial femoral artery","volume":"11","author":"Miura","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib67","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3390\/jcm9072221","article-title":"Assessment of mortality and factors affecting outcome of use of paclitaxel-coated stents and bare metal stents in femoropopliteal PAD","volume":"9","author":"Falkowski","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejvs.2026.01.030_bib68","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.122.059606","article-title":"Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trial","volume":"146","author":"Gou\u00ebffic","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2026.01.030_bib69","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(25)01584-3","article-title":"Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial","volume":"406","author":"Nordanstig","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2026.01.030_bib70","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1526602815626557","article-title":"Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability","volume":"23","author":"Katsanos","year":"2016","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.ejvs.2026.01.030_bib71","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(25)01585-5","article-title":"Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial","volume":"406","author":"Falkenberg","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2026.01.030_bib72","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012074","article-title":"Update from the longitudinal assessment of safety of femoropopliteal endovascular treatment with paclitaxel-coated devices among medicare beneficiaries: the SAFE-PAD study","volume":"15","author":"Secemsky","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008528","article-title":"Mortality after paclitaxel coated balloon angioplasty and stenting of superficial femoral and popliteal artery in the vascular quality initiative","volume":"13","author":"Bertges","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2026.01.030_bib74","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jvir.2021.03.537","article-title":"The rollercoaster of paclitaxel in the lower limbs and skeletons in the closet: an opinion review","volume":"32","author":"Katsanos","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ejvs.2026.01.030_bib75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor\u2019s choice\u2014European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588426000663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588426000663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:24:33Z","timestamp":1780622673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588426000663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1078588426000663"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2026.01.030","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editor's Choice \u2013 Dynamic Risk of Death following Application of Paclitaxel Coated Devices in the Femoropopliteal Artery: A Contemporary Meta-analysis of Randomised Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2026.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}